TFEB and liver dysplastic nodule: Thus, lysosomal enhancement by both TFEB overexpression and pharmacological activation of endogenous TFEB could potentially be used to maintain lysosomal homeostasis and may be an attractive therapeutic approach to retard the progression of DN.